The objective of the study was to determine the feasibility of detecting fetal brain lactate, a marker of fetal metabolic acidemia, using a noninvasive technique, proton magnetic resonance spectroscopy ( 1 H MRS), in intrauterine growth-restricted (IUGR) fetuses.
M
anagement and timing of delivery of intrauterine growth-restricted (IUGR) fetuses remains a central issue for obstetricians, because the risk of perinatal death has to be balanced with the cost of prematurity.
1,2 Current available surveillance tests seem to have little impact on improving long-term neurodevelopmental outcome. 3, 4 Therefore, new markers of neurological damage should be sought, based on the understanding of the adaptive processes occurring in the human fetal brain during growth restriction.
Proton magnetic resonance spectroscopy ( 1 H MRS) is a noninvasive imaging technique that allows obtaining in vivo metabolic information from the brain. 5 Brain 1 H MRS identifies several metabolites of biological importance, including lactate. 6 It has been demonstrated that elevated levels of lactate detected by 1 H MRS in the brain of asphyxiated neonates are predictive of neurodevelopmental delay. 7, 8 Plasma lactic acid concentration is indeed higher in IUGR fetuses with altered umbilical arterial Doppler velocimetry and abnormal fetal heart rate 9, 10 ; however, little is known about intrauterine changes in cerebral metabolism in IUGR fetuses.
In recent years, the fetal brain metabolic profile has been described in utero in uncomplicated pregnancy by 1 H MRS during the second and third trimesters. [11] [12] [13] [14] Such studies have failed to detect lactate in the normal fetal brain. However, several authors have recently suggested that the potential evidence of cerebral lactate is an indicator of altered fetal cerebral metabolism in pathological conditions. [15] [16] [17] In this study, we sought to measure fetal cerebral lactate using 1 H MRS to evaluate whether it could represent a marker of brain damage in IUGR fetuses.
Study population
We studied 5 singleton pregnancies complicated by IUGR between 28 and 37 weeks of gestation. Gestational age was calculated from the last menstrual period and confirmed by routine ultrasonography at 11-12 weeks of gestation.
We identified growth-restricted fetuses in utero through repeated longitudinal measurements that demonstrated a reduction in fetal growth velocity and further classified them according to umbilical arterial Doppler velocimetry and fetal heart rate (FHR) tracing. 2, 10, 18 Specifically, IUGR was defined by measurements of abdominal circumferences below the 10th percentile of reference values for fetuses of similar ages together with a shift from the growth curve greater than 40 centiles. 19 As an example, this represents a decrease from the 50th centile (measured at 20 weeks) to below the 10th centile (at the time of IUGR diagnosis). Growth restriction was confirmed at birth, if the neonatal weight was below the 10th percentile according to Italian standards for birth weight and gestational age. 20 None of the fetuses were affected with abnormal karyotype, genetic syndromes, viral infection, or major malformations.
Antenatal fetal surveillance was conducted by multivessel arterial and venous Doppler velocimetry and FHR evaluation. Doppler waveforms were obtained from uterine arteries, umbilical artery (UA), middle cerebral artery (MCA), and ductus venosus. Uterine arteries Doppler velocimetry was considered altered, if the pulsatility index (PI) was 2 SDs above the mean for gestational age on both sides. UA Doppler waveform was considered abnormal, if the PI was 2 SDs above the mean for gestational age. End-diastolic velocity was classified as either present, absent, or reversed. In the MCA, a PI more than 2 SDs above the mean for gestational age was defined as brain sparing, indicating abnormally reduced impedance to flow in the cerebral circulation. 21 Ductus venosus velocity during atrial systole was characterized as forward or absent/reversed. 21 FHR was considered abnormal, if at least 1 of the following patterns was present: less than 2 accelerations of the heart rate to an amplitude of 10 or more beats per minute lasting 15 seconds or more during a period of at least 30 minutes; variability of 5 or fewer beats per minute during a period of at least 60 minutes; and U-shaped (late) decelerations in the heart rate after Braxton Hicks contractions.
IUGR fetuses were classified into 3 groups of increasing clinical severity based on Doppler velocimetry of the umbilical artery and FHR as previously proposed. 10 Briefly, type 1 IUGR showed both normal PI and FHR; type 2 IUGR had abnormal PI and normal FHR; and type 3 IUGR showed both abnormal parameters.
In the IUGR subjects, the concomitant presence of preeclampsia was defined as the onset of gestational hypertension and proteinuria after 20 weeks of gestation. 22 Hypertension was defined as 2 or more recordings of a diastolic blood pressure of 90 mm Hg or more taken at least 4 hours apart. Proteinuria was considered as the excretion of 300 mg protein or more over a 24 hour period. 22 Preeclampsia was classified as severe, if 1 or more of the following criteria were present: blood pressure of 160/110 mm Hg or greater on 2 occasions on bed rest; proteinuria of 5 g or greater in a 24 hour urine specimen or 3 or greater on 2 random urine samples; oliguria; cerebral or visual disturbances; pulmonary edema or cyanosis; epigastric or right upperquadrant pain; impaired liver function; and thrombocytopenia. 23 Severe preeclampsia was considered further complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count) in the presence of hemolysis (lactate dehydrogenase Ͼ600 U/L), low platelets (Ͻ100,000/L), and elevated liver enzymes (aspartate aminotransferase Ͼ70 U/L). 24 Timing and route of delivery were decided based on maternal and/or fetal parameters, according to our clinical protocol.
Days of hospitalization in the neonatal intensive care unit (NICU) and major neonatal complications were recorded.
MR procedures

Fetal brain MRI
All magnetic resonance (MR) examinations were performed on an MR system operating at 1.5 Tesla (Avanto, Siemens, Germany). No fetal sedation was used. Body-phased array coils were used in combination with spinal coils. The standard MR protocol included gradientecho T1-weighted images following the 3 planes of the fetal head and single-shot T2-weighted images (half-Fourier acquisition, single-shot, turbo spin-echo [HASTE] sequence). Three-dimensional T2-weighted images (true fast imaging with steady precession, True-FISP sequence) were also acquired as needed.
Fetal localized brain magnetic resonance spectroscopy (MRS)
After the standard MRI protocol, to limit the time of the procedure as much as possible, the spectra were acquired with a single volume of interest (VOI) spinecho sequence (PRESS). We located the VOI in the central brain areas (cerebral hemispheres; Figure 1 ), with the VOI centered on the midline to prevent any possible inclusion of scalp and extracranial tissues. To limit as much as possible any potential contamination from adjacent lipids during the acquisition of brain spectra, we ascertained whether the position of the fetal head was unchanged at the end of the 1 H MRS sequence by performing a rapid MRI (localizer) examination 12 to obtain spectra with a sufficient signal-to-noise ratio (SNR) in the shortest time possible.
Depending on the size of the fetal brain, the volume of the voxel was chosen to be between 10 and 24 cc to acquire MR spectra with sufficient SNR in a reasonable time. Sequences were performed with and without water saturation. The MRS parameters for the water suppressed spectra were as follows: echo time ϭ 135 milliseconds, repetition time ϭ 4000 milliseconds, 64 acquisitions. Total acquisition time (imaging and spectroscopy) was limited within 30 minutes in all cases. Data were processed with the use of jMRUI. 25 The jMRUI is a software package used for the processing of MRS and MRSI data in the time domain (http://www.mrui.uab.es).
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Data processing consisted of zero filling (2048 points), Gaussian filtering (4 Hz), Fourier transformation, and zeroorder phase correction. No baseline correction was applied. The presence of the typical lactate signal, visible as an inverted doublet at the echo time used, was searched at 1.33 ppm.
Spectra were normalized to the N-acetylaspartate (NAA) peak. NAA is well detected and can be unambiguosly identified by MRS.
Oxygenation and acid-base balance at birth
Umbilical arterial and venous blood samples were obtained from a clamped segment of the cord immediately after delivery. Blood samples were collected into heparinized syringes and stored on ice until analyses. Fetal hemoglobin concentration (Hb), umbilical arterial and venous oxygen saturation, pH, pO2, pCO2, and lactate concentration were measured on a GEM Premier 3000 (Instrumentation Laboratory, Lexington, MA). Oxygen content was calculated according to the formula: O 2 content (millimoles) ϭ Hb concentration (grams per liter) ϫ O 2 saturation ϫ 0.05982.
10
Statistical analysis
Data are presented as mean Ϯ SD. Analyses were performed using SPSS Statistics Desktop (SPSS, Chicago, IL).
RESULTS
Maternal age ranged between 29 and 35 years (mean, 31.8 Ϯ 2.3 years) and maternal body mass index between 18 and 22 kg/m 2 (mean, 20.4 Ϯ 1.5 kg/m 2 ). Tables 1 and 2 present the characteristics of the IUGR population at the time of MRS study and at the time of delivery, respectively. Gestational age at the time of MRS and at the time of delivery ranged from 28.2 to 37.0 weeks (mean, 32.6 Ϯ 3.4 weeks) and from 28.5 to 38.5 weeks (mean, 33.5 Ϯ 2.5 weeks), respectively. Time between MRS and delivery was 2-12 days (mean, 5 Ϯ 4 days). Femalemale sex ratio was 4:1.
Antenatal Doppler characteristics of each single case are presented in Table 1 . Cases 1 and 2 were classified as IUGR type 1. They presented an abdominal circumference between the fifth and 10th percentile of reference values, normal Doppler velocimetry in uterine arteries, umbilical artery, mean cerebral artery and ductus venosus, and normal FHR. Fetus 1 had a single umbilical artery and did not present any major malformations at birth.
In case 2, the mother was affected by idiopathic thrombocythemia (platelet count approximately 500,000/L), which was stable during pregnancy. She developed pregnancy-induced hypertension at 33 weeks of gestational age and was treated with nifedipine 30 mg per os 3 times a day, according to our clinical protocol. At 35 weeks' gestation, she developed mild proteinuria and underwent labour induction at 35.4 weeks' gestation. A dinoprostone vaginal insert was applied and removed 15 hours later because of nonreassuring FHR, and cesarean section was performed. 
Location of the VOI for MRS
The parasagittal T2-weighted image, case 4, is shown. Cases 3 and 4 were classified as IUGR type 2. They presented a more severe growth restriction than the previous cases (abdominal circumference below the fifth percentile) with oligohydramnios, altered umbilical arterial PI, brain sparing, and normal FHR. Fetus 3 showed mild cerebral ventriculomegaly on ultrasound scan (lateral ventricular size 12 mm), which was confirmed by standard MRI. Patient 3 developed preeclampsia at 30 weeks and was treated with nifedipine.
Case 5 was a severe IUGR fetus (IUGR type 3) with abdominal circumference below the first percentile, oligohydramnios, and altered umbilical arterial PI and FHR. The mother was affected by severe preeclampsia, had been treated with nifedipine, and developed the HELLP syndrome. Four infants were delivered by cesarean section without labor for fetal indications, and 1 patient underwent cesarean section after labor induction (case 2).
Data at delivery are presented in Table 2 . No fetal or neonatal deaths occurred. Oxygenation and acid-base balance data at delivery are presented in Table 3 . Case 5, the most severe IUGR fetus (IUGR type 3), presented the lowest oxygen content and the highest lactic acid concentration at birth. Lactic acid concentration was also high at birth in case 4 (IUGR type 2), who was delivered because of altered FHR, and in case 2 (IUGR type 1), a fetus with mild growth restriction who underwent induction of labor, which affected acid-base balance at birth.
Case 1 did not require admission to the NICU. Cases 2 and 3 needed hospitalization in the NICU for 10 and 36 days, respectively, but showed no major neonatal complications. Case 4 experienced respiratory distress syndrome (RDS) and stayed in the NICU 63 days. Case 5 had RDS and underwent 2 episodes of neonatal sepsis. He was discharged from the NICU after 123 days.
MRS studies
In the cases with less severe IUGR (IUGR types 1 or 2), no lactate peak was detectable (Table 3 ). In the most severe case (case 5, IUGR type3), a lactate peak was clearly visible in the spectrum (Table 3) , as shown in Figure 2 .
COMMENT
Principal findings
In this study, we demonstrate a significant lactic acid peak in the brain of a severely growth-restricted fetus. In this patient, MRS was performed at 28 weeks when reverse flow in the umbilical artery was evident and FHR was abnormal. We have previously shown that approximately 80% of IUGR with these abnormalities are associated with hypoxia and lactacidemia evaluated in utero by fetal blood sampling. 10 Similarly, our case of severe IUGR showed reduced levels of oxygen content and increased levels of lactic acid in the umbilical artery and vein at the time of delivery (72 hours after MRS) (Table 3) . Moreover, the finding that lactic acid concentrations were higher in the umbil- 
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Obstetrics Research ical artery than in the umbilical vein demonstrates that lactate was produced by the fetus because of anaerobic metabolism, as previously described. 9 Our finding is in agreement with 2 previous studies that reported the presence of lactate by fetal brain MRS in IUGR fetuses. 17, 26 Both studies, however, lack data about oxygenation and acid-base balance at delivery.
Interestingly, we did not detect any lactic acid peak in the spectra obtained by MRS in the other IUGR fetuses studied, even though we cannot exclude the presence of cerebral lactate in amounts below the minimal level of detection of 0.5-1 mM. Although in 2 of these cases umbilical, as well as cerebral, arterial Doppler velocimetry was abnormal and amniotic fluid index was reduced, umbilical oxygen and lactate levels were normal at delivery in 3 of 4 cases in which brain lactate could not be detected by MRS. In only 1 case (case 2), umbilical lactate concentration was high because of the induction of labor, uterine contractions, and consequent fetal distress, as indicated by alterations of FHR before cesarean section was decided. Therefore, hypoxemia at birth in this case was reasonably acute because of the stress of labor.
Caution needs to be applied in making any direct correlation between umbilical lactate concentration measured at birth and brain lactate detected by MRS for several reasons: (1) different intervals of time elapsed between MRS and birth (2-12 days); (2) little knowledge about the mechanisms of lactate transport through the hematoencephalic barrier during intrauterine life 27 ; and (3) impossibility of excluding that lactate below the minimal level of detection of 0.5-1 mM is present in the fetal brain. Nevertheless, our results indicate that, in hypoxic IUGR fetuses with increased lactacidemia because of anaerobic metabolism, cerebral lactate is also evident.
Detection of lactate in the fetal brain may indeed represent an indirect sign of energy failure because of reduced adenosine-5=-triphosphate production and mitochondrial function impairment. 28 In fetal lambs, the degree of cerebral lactate accumulation studied by MRS is as- 
Fetal brain lactate detection
The region of the spectra between 1.00 and 2.25 ppm is represented. A, In the most severe IUGR case (case 5, IUGR type 3), lactate is clearly detectable, because the typical inverted doublet is centered at 1.33 ppm. B, Conversely, no lactate peak is detected in a case of similar gestational age but with a less severe IUGR (case 4, IUGR type 2). Spectra A and B are normalized to the NAA peak. sociated with the severity of hypoxic brain damage. 29 Newborn piglets with IUGR show increased cerebral lactate during hypoxia, compared with normalweight piglets, and this is inversely associated with the degree of apoptosis, indicating different cerebral metabolism in IUGR brain. 30 IUGR is a heterogeneous condition, associated with a specific placental phenotype and with different levels of severity. 31 We have previously shown that a definition of IUGR based on a reduction of growth rate of the abdominal circumference is able to identify fetuses that experience a significant reduction in nutrients delivery and utilization, 32, 33 although not invariably hypoxemic and lactacidemic. 10 Moreover, whereas redistribution of blood flows with brain sparing occurs, preliminary data now suggest that the fetus adapts to an inadequate environment also with hypometabolism, reducing oxygen consumption on a per-kilogram basis. 34, 35 However, failure of these mechanisms finally occurs and timing of delivery is still the best option to avoid brain damage, although the identification of this time point is still a challenge. Moreover, the ideal marker of brain damage has still to be identified, because neurostructural correlations with observed developmental disabilities have not yet been established. We have recently reported a mild delay in myelination at 40 weeks postconceptional age in IUGR that present brain sparing in utero, with no apparent brain lesions at MRI. 36 
Potential limitations
A potential limitation of our study is represented by the great variability in gestational age among the IUGR cases. Case 5, the most severe, was also the most premature. However, previous MRS studies have not observed any detectable lactate peak in the brain of normal fetuses at any gestational age in the second half of pregnancy. 12 Nonetheless, we cannot exlude that lactate is present in the fetal brain at low and nonsignificant levels and may act as a fuel also in normal conditions. 37 Moreover, the time the MRS and the umbilical blood sampling can represent a potential limitation in making direct correlations between the 2 findings.
CONCLUSIONS
We demonstrated the presence of cerebral lactate detected in vivo in a severe IUGR fetus with hypoxia and lactacidemia at delivery. Lactate detected by MRS may therefore, represent a marker of altered fetal brain metabolism and potential brain damage in IUGR. Further experimental and clinical investigations may help to understand the natural history of IUGR and to evaluate the efficacy of fetal brain MRS in the clinical setting.
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